PD-L1-Guided Chemo-Immunotherapy in Advanced Triple-Negative Breast Cancer: A Meta-Analysis of Survival Benefits and Toxicity Profiles.

Cancers (Basel) · 2026 · PMC13162691 · PMID 42122148

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Regarding race, White patients derived significant benefit (HR 0.76, 95% CI 0.66–0.88), whereas results for Asian (HR 0.83, 95% CI 0.65–1.07) and Black patients (HR 0.83, 95% CI 0.51–1.37) did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.